Next, we sought to test the influence of TACC3 on EGFR signaling in NSCLC cells and tested whether the targeting of TACC3 has an effect on NSCLC cells that are resistant to TKI treatment. The gene discussed is TACC3; the disease is non-small cell lung carcinoma.